Our Pricing

Wegovy All Doses In Stock UK Today

Published on: June 03, 2026

Finding wegovy all doses in stock uk has been challenging throughout 2024, but Cured Pharmacy maintains reliable availability across the complete dose range from 0.25mg to 2.4mg. As a UK-registered pharmacy (GPhC 9012511) with transparent upfront pricing from £79.00, we offer genuine UK-licensed Wegovy pens with free clinical consultation and discreet next-day delivery.

Complete Wegovy Dose Range Available

Wegovy (semaglutide) follows a structured dose escalation schedule designed to minimise gastrointestinal side effects whilst optimising weight loss outcomes. The full UK-licensed dose range includes 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg pre-filled injection pens [1].

Each dose strength serves a specific clinical purpose. The initial 0.25mg and 0.5mg doses allow your body to adjust to semaglutide gradually, reducing the likelihood of nausea and vomiting. The maintenance dose of 2.4mg, reached after 16 weeks, delivers the maximum therapeutic effect demonstrated in clinical trials [1][2].

Stock shortages across UK pharmacies throughout 2024 have particularly affected the starter doses (0.25mg and 0.5mg), causing treatment interruptions for thousands of patients. At Cured Pharmacy, our superintendent pharmacist Tarun Kumar (GPhC 2233073) maintains consistent supply relationships to ensure all doses remain available for continuing patients and new starters alike.

How Wegovy Delivers Clinical Weight Loss

Semaglutide, the active ingredient in Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your intestines release after eating [2]. This mechanism works through three primary pathways: slowing gastric emptying so you feel fuller longer, reducing appetite signals in the brain, and improving insulin sensitivity.

The STEP 1 clinical trial demonstrated that adults using Wegovy 2.4mg achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [2]. Importantly, 83.5% of participants lost at least 5% of their body weight, and 66.1% lost at least 10% — thresholds associated with significant metabolic health improvements [2].

These results represent substantial advances over previous weight loss medications. The once-weekly injection format improves adherence compared to daily treatments, and the dose escalation protocol allows most patients to reach the full therapeutic dose with manageable side effects [3].

Expected Timeline for Results

Most patients notice appetite reduction within the first week of treatment, though significant weight loss typically becomes apparent after reaching the 1mg dose around week 8. Maximum weight loss generally occurs between months 6 and 12 of continuous treatment at the 2.4mg maintenance dose, subject to individual response and lifestyle factors [2][3].

Wegovy Dosing Schedule Explained

The UK-licensed Wegovy dosing protocol follows a specific 20-week escalation schedule. You begin with 0.25mg once weekly for 4 weeks, increase to 0.5mg for 4 weeks, then 1mg for 4 weeks, followed by 1.7mg for 4 weeks, before reaching the maintenance dose of 2.4mg [1].

This gradual increase serves a critical clinical purpose. GLP-1 receptor agonists commonly cause gastrointestinal side effects — particularly nausea, vomiting, and diarrhoea — when introduced too quickly. The escalation schedule allows your digestive system to adapt whilst still achieving therapeutic blood levels [3].

If you experience persistent side effects at any dose, your UK prescriber may recommend staying at your current dose for an additional 4 weeks before escalating. Some patients achieve satisfactory weight loss at 1mg or 1.7mg and may not require the full 2.4mg dose, though this decision must be made under medical supervision [3].

What Happens If You Miss a Dose

If you miss a Wegovy injection and your next scheduled dose is more than 2 days away, take the missed dose as soon as you remember. If your next dose is within 2 days, skip the missed dose and resume your regular schedule. Never take two doses within 48 hours to make up for a missed injection [1].

Wegovy vs Alternative Weight Loss Treatments

Several prescription weight loss medications are now licensed in the UK, each with distinct mechanisms and clinical profiles. Understanding these differences helps you and your prescriber select the most appropriate treatment for your circumstances.

Mounjaro (tirzepatide) is a newer dual GIP/GLP-1 receptor agonist that activates two hormone pathways rather than one. Head-to-head trials suggest tirzepatide may produce slightly greater weight loss than semaglutide, with SURMOUNT-1 showing average reductions of 20.9% at the highest dose [4]. However, Mounjaro follows a different dose escalation schedule and may not suit everyone.

Saxenda (liraglutide) is an earlier GLP-1 medication requiring daily injections rather than weekly. Whilst effective, the daily administration and generally lower weight loss outcomes (average 8% in trials) make it less convenient for most patients [5]. Oral medications like Mysimba (naltrexone/bupropion) and Orlistat work through entirely different mechanisms and typically produce more modest results.

Your UK prescriber will consider your medical history, previous weight loss attempts, other medications, and personal preferences when recommending treatment. All options require ongoing lifestyle modifications including dietary changes and increased physical activity for optimal results.

Managing Wegovy Side Effects

The most common side effects of Wegovy affect the gastrointestinal system. In clinical trials, nausea occurred in approximately 44% of participants, diarrhoea in 30%, vomiting in 24%, and constipation in 24% [2]. These effects typically peak during dose escalation and diminish as your body adapts to the medication.

Practical strategies can significantly reduce side effect severity. Eat smaller, more frequent meals rather than large portions. Avoid high-fat and spicy foods, which can exacerbate nausea. Stay well-hydrated, particularly if experiencing vomiting or diarrhoea. Inject Wegovy at bedtime so peak nausea occurs during sleep rather than daytime hours [3].

Serious side effects are rare but require immediate medical attention. Contact your GP or NHS 111 if you experience severe abdominal pain that doesn't resolve (possible pancreatitis), changes in vision, signs of thyroid swelling, or symptoms of gallbladder problems including yellowing skin or eyes [1]. Wegovy carries a boxed warning regarding thyroid C-cell tumours observed in animal studies, though no causal relationship has been established in humans [1].

Your UK prescriber will review your complete medical history before prescribing Wegovy. The medication is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and should be used cautiously in those with history of pancreatitis or diabetic retinopathy [1].

When to Contact Your Prescriber

Reach out to your prescriber if side effects persist beyond the first month at a new dose, if you're unable to eat or drink due to nausea and vomiting, or if you experience no weight loss after 12 weeks at the 2.4mg maintenance dose. Your treatment plan may need adjustment based on your individual response.

Wegovy Pricing and Prescription Process at Cured Pharmacy

Wegovy is available from £79.00 at Cured Pharmacy, with transparent pricing displayed before you begin your consultation. As a prescription-only medication, Wegovy requires clinical assessment by a UK-registered prescriber before dispensing, in accordance with MHRA regulations and GPhC standards.

Our streamlined online consultation takes under 3 minutes and covers your medical history, current medications, weight loss goals, and any contraindications. A UK prescriber reviews your responses, typically within hours, and approves treatment if clinically appropriate. You'll never pay consultation fees — the service is included in your medication price.

Once approved, your Wegovy prescription is dispensed from our UK-registered pharmacy and shipped in 100% discreet packaging with next-day delivery options. Each pen arrives with full patient information, injection instructions, and access to our clinical team for ongoing support throughout your treatment journey.

Continuing prescriptions are equally straightforward. When you're ready for your next dose, simply complete a brief follow-up consultation confirming your progress and any side effects. Our system tracks your dose escalation schedule to ensure you receive the correct strength at the appropriate time, eliminating the confusion that often accompanies multi-month weight loss treatments.

Scientific References

1. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Garvey, W. T., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4 [accessed 13 August 2026]
4. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
5. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine and must be used under medical supervision as part of a comprehensive weight management programme including diet and exercise.